Dapagliflozin Protects Methamphetamine-Induced Cardiomyopathy by Alleviating Mitochondrial Damage and Reducing Cardiac Function Decline in a Mouse Model

Background: Methamphetamine (METH)-induced cardiovascular toxicity has been attributed to its destructive effect on mitochondrial function at least to some extent. Previous studies highlighted the benefits of dapagliflozin (DAPA) on the cardiovascular system, but the response of METH-induced cardiom...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Shanqing, Yao, Yajun, Yang, Nan, Wang, Youcheng, Liu, Dishiwen, Cao, Zhen, Chen, Huiyu, Fu, Yuntao, Yang, Mei, Wang, Songjun, He, Guangjie, Zhao, Qingyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301370/
https://www.ncbi.nlm.nih.gov/pubmed/35873593
http://dx.doi.org/10.3389/fphar.2022.925276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301370/
https://www.ncbi.nlm.nih.gov/pubmed/35873593
http://dx.doi.org/10.3389/fphar.2022.925276

Ejemplares similares